Page last updated: 2024-09-05

dn 108 and deferoxamine

dn 108 has been researched along with deferoxamine in 1 studies

Compound Research Comparison

Studies (dn 108)	Trials (dn 108)	Recent Studies (post-2010) (dn 108)	Studies (deferoxamine)	Trials (deferoxamine)	Recent Studies (post-2010) (deferoxamine)
7	0	1	6,703	240	1,266

Protein Interaction Comparison

Protein	Taxonomy	dn 108 (IC50)	deferoxamine (IC50)
Lysine-specific demethylase 4A	Homo sapiens (human)		3.275
Deoxyhypusine hydroxylase	Homo sapiens (human)		5

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dirnagl, U; Isaev, N; Karsch, M; Megow, D; Meisel, A; Prass, K; Priller, J; Ruscher, K; Scharff, A	1

Other Studies

1 other study(ies) available for dn 108 and deferoxamine

Article	Year
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Constriction; Cycloheximide; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Erythropoietin; Gene Expression; Glucose; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neurons; Nuclear Proteins; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors	2002

Article

Year

Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:5

Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Constriction; Cycloheximide; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Erythropoietin; Gene Expression; Glucose; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neurons; Nuclear Proteins; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors

2002